SITRA

Sitra is a private equity and venture capital firm based in Helsinki, Finland. Established in 1967, it operates as the venture capital investment arm of Sitra and specializes in fund of fund investments, targeting private equity funds, real estate funds, and venture capital funds. The firm actively engages in the management of its investments, often nominating representatives to the boards of its portfolio companies. Sitra's investment focus is structured around three key programmes: Health Care, Food and Nutrition, and Environmental. The Health Care Programme emphasizes investments in innovative companies that enhance healthcare delivery and technology, while the Food and Nutrition Programme targets enterprises that improve food production and technology. Additionally, Sitra aims to foster economic growth and international competitiveness in Finland by supporting projects that enhance economic efficiency, education, and research.

Juuso Janhonen

Portfolio Manager, Venture Capital

Mikko Kosonen

President

Sami Tuhkanen

Vice President, Investments

15 past transactions

SET Ventures

Funding Round in 2019
SET Ventures is a venture capital firm established in 2007 and based in Amsterdam, Netherlands. It specializes in early to mid-stage investments in European technology companies, particularly within the energy and renewable sectors. The firm concentrates on innovative energy generation, distribution, storage, and efficiency technologies. Its investment strategy encompasses smart energy solutions, which integrate intelligent software and services with hardware components. Key areas of focus include renewable energy sources such as solar, wind, and bioenergy, as well as advanced energy storage technologies and energy-efficient applications in buildings and transportation. SET Ventures typically invests between €0.5 million and €6 million in each portfolio company, aiming to support ventures that contribute to the transition of the energy system. The firm also emphasizes the importance of taking active roles in its investments, often seeking seats on supervisory boards to guide the companies it supports.

Headai

Grant in 2018
Headai Ltd. is a Finnish company established in 2015, specializing in the development of software robots designed to automate various intellectual tasks in business operations. The company offers teachable software robots as a cloud service, enabling users to automate repetitive processes and enhance productivity. Headai focuses on General Semantic AI, which promotes transparent, data-driven decision-making across diverse sectors, including labor markets, investment, and education. Their technology integrates natural language processing and advanced learning algorithms, allowing for interactive and reliable assistance. Headai aims to provide clients with efficient corporate learning solutions and facilitate the discovery of relevant content tailored to individual interests.

Naava

Venture Round in 2017
Naava specializes in developing living green walls technology aimed at improving indoor air quality and enhancing overall well-being. By utilizing bioactive plants, Naava creates environments that purify air, reduce harmful chemicals, and provide natural humidity, making it easier for individuals and businesses to incorporate the benefits of nature into their indoor spaces. The company's innovative solutions address the need for healthier living and working environments, especially as people spend a significant portion of their time indoors, often exposed to synthetic air. Naava's mission is to reconnect people with nature, allowing them to experience the refreshing quality of Nordic forest air, even in urban settings.

Optomeditech

Venture Round in 2014
Optomeditech Oy is a Finnish company based in Espoo, established in 2011. It focuses on developing and marketing products related to intravenous catheters and blood collection needles. The company is currently engaged in obtaining necessary regulatory approvals, specifically the CE mark and FDA 510(k) approval, for its initial intravenous catheter product, with plans to enter the market in the near future.

NaturVention

Venture Round in 2014
NaturVention Enclosed Ecosystem Technologies solves global problems by combining nature and technology. We are a fast growing, venture-backed technology company. We challenge ourselves to find solutions to global problems by looking into nature, from where we have been able to find solutions for thousands of years already. We have developed patented solutions by enhancing nature’s own processes. We use the brightest technology to enhance those processes in order to create products that are easy to use and which help people to feel better by providing clean and healthy air and food.

Omegawave

Venture Round in 2013
Omegawave Oy develops training and performance management solutions aimed at enhancing the effectiveness of athletes, teams, and coaches. The company offers products like Omegawave Team and Omegawave Coach, which provide comprehensive assessments of athlete readiness, along with analyses of heart rate variability (HRV), central nervous system (CNS) activity, and training trends. These solutions facilitate real-time data integration into training processes, allowing coaches to make informed decisions while helping athletes optimize their performance and minimize the risk of injuries. Omegawave's technology is utilized by various elite sports organizations, including multiple Olympic Federations and professional teams from major leagues such as the NFL, MLS, NHL, and MLB. Founded in 1999 and headquartered in Espoo, Finland, Omegawave serves a global clientele, with customers in countries such as China, Hungary, and South Africa, among others. The company has been recognized for its contributions to sports technology, including being awarded for the best performance technology for elite athletes.

Omegawave

Seed Round in 2013
Omegawave Oy develops training and performance management solutions aimed at enhancing the effectiveness of athletes, teams, and coaches. The company offers products like Omegawave Team and Omegawave Coach, which provide comprehensive assessments of athlete readiness, along with analyses of heart rate variability (HRV), central nervous system (CNS) activity, and training trends. These solutions facilitate real-time data integration into training processes, allowing coaches to make informed decisions while helping athletes optimize their performance and minimize the risk of injuries. Omegawave's technology is utilized by various elite sports organizations, including multiple Olympic Federations and professional teams from major leagues such as the NFL, MLS, NHL, and MLB. Founded in 1999 and headquartered in Espoo, Finland, Omegawave serves a global clientele, with customers in countries such as China, Hungary, and South Africa, among others. The company has been recognized for its contributions to sports technology, including being awarded for the best performance technology for elite athletes.

Visionplus

Venture Round in 2012
VisionPlus is a venture capital firm based in Helsinki, Finland, established in 2011. The company focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment strategy encompasses software-as-a-service, gaming, mobile applications, and internet services. Additionally, VisionPlus occasionally engages in special content intellectual property deals. The firm's management team possesses substantial expertise in technology and entrepreneurship, with experience in seed investments and the successful development of new products and services. Members of the team have also led large-scale development and business organizations in a global context.

Savosolar

Venture Round in 2011
Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim

Venture Round in 2011
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

Nexstim

Venture Round in 2007
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

FIT Biotech

Venture Round in 2006
FIT Biotech Oy operates as a clinical-stage biotech company. The company focuses on developing antibody gene delivery technologies and gene vaccines for cancer immunotherapy, and the prevention and treatment of infectious diseases, such as HIV and tuberculosis, as well as animal vaccines. The company develops and licenses its patented gene transport unit (GTU) vector technology for new-generation medical treatments. It also markets FIT-06, a GTU-based DNA vaccine, for the treatment of HIV patients. It has a research collaboration agreement with Avacta Group plc to develop gene therapies. FIT Biotech Oy was founded in 1995 and is based in Tampere, Finland.

Vivoxid

Venture Round in 2005
Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces; BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction; and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi-Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies

Series C in 2005
Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.

AW-Energy

Series A in 2004
AW-Energy Oy is a Finnish company that specializes in the design, development, and manufacture of wave energy generation equipment. Founded in 2002 and based in Vantaa, the company has created the WaveRoller, a submerged wave energy converter that transforms ocean wave energy into electricity. The WaveRoller operates by harnessing the wave surge phenomenon, where the circular motion of water particles in open sea waves transitions to a horizontal back-and-forth movement in shallow waters. This movement drives piston pumps that generate hydraulic pressure, which is converted into electricity through a motor/generator system. Each WaveRoller unit can produce between 500 and 1,000 kW, depending on local wave conditions, and multiple units can be combined to form a scalable wave farm. The modular design allows for flexibility in construction and operation, ensuring consistent energy output even if individual units require maintenance. Since its initial prototype development in 1999, AW-Energy has conducted extensive testing in various marine environments, including the Gulf of Finland and Portugal, leading to successful deployment of demonstration plants connected to national grids.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.